Shawah Robert G.
SEC insider (Form 3/4/5 filer). CIK 0001601121. Chief Financial Officer at Acurx Pharmaceuticals, Inc. (ACXP). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 20, 2026. Located in STATEN ISLAND, NY.
Companies Shawah Robert G. has filed insider reports for
- Acurx Pharmaceuticals, Inc. (ACXP): Officer, Chief Financial Officer
Shawah Robert G.
CIK: 0001601121
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACXP
Acurx Pharmaceuticals, Inc.
Officer